Jpn J Nurs Sci:与BD Venflon™相比,BD Insyte™ Autoguard™ BC winge导管静脉炎的发生率较低

2020-11-15 MedSci原创 MedSci原创

本研究旨在确定两类导管材料(维亚隆生物材料和特氟隆)对外周静脉导管(PIVC)置管的疼痛强度、停留时间和静脉炎评分的影响,研究结果已在线发表于pn J Nurs Sci。

本研究旨在确定两类导管材料(维亚隆生物材料和特氟隆)对外周静脉导管(PIVC)置管的疼痛强度、停留时间和静脉炎评分的影响,研究结果已在线发表于pn J Nurs Sci。
 
 
将参与者(N = 208)随机分配到vialon生物材料组(n = 104)和特氟隆组(n = 104)。PIVC置管后,评估疼痛强度和静脉炎评分。测定导管滞留平均时间。
 
结果显示,插入PIVC后,两组患者的疼痛强度评分相似,疼痛评分之间无差异(P≥.050)。与特氟龙导管组(4.10±0.92天)相比,vialon生物材料导管组的导管滞留平均时间(4.72±1.20天)明显延长(p≤.001)。经测定,vialon生物材料导管组和特氟龙导管组分别有16.3%和53.8%的导管因静脉炎而被拔除。两组在静脉炎发展评分方面存在统计学差异(P≤.001)。
 
综上所述,该研究结果表明,vialon生物材料导管(BD Insyte™ Autoguard™ BC winged)比特氟隆导管(BD Venflon™)表现出更长的PIVC滞留时间、更低的静脉炎发生率和静脉炎评分。
 
原始出处:
 
Betül Kuş, Funda Büyükyılmaz, et al., Effectiveness of vialon biomaterial versus teflon catheters for peripheral intravenous placement: A randomized clinical trial. Jpn J Nurs Sci. 2020 Jul;17(3):e12328.  doi: 10.1111/jjns.12328. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1698166, encodeId=09651698166c1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 31 10:14:52 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826648, encodeId=b55218266489d, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jun 29 17:14:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423592, encodeId=02d21423592cf, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454873, encodeId=ff1e14548e331, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899345, encodeId=f16789934520, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71f65411944, createdName=ms4000000798581120, createdTime=Sun Nov 15 18:01:08 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
    2021-07-31 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1698166, encodeId=09651698166c1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 31 10:14:52 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826648, encodeId=b55218266489d, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jun 29 17:14:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423592, encodeId=02d21423592cf, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454873, encodeId=ff1e14548e331, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899345, encodeId=f16789934520, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71f65411944, createdName=ms4000000798581120, createdTime=Sun Nov 15 18:01:08 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1698166, encodeId=09651698166c1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 31 10:14:52 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826648, encodeId=b55218266489d, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jun 29 17:14:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423592, encodeId=02d21423592cf, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454873, encodeId=ff1e14548e331, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899345, encodeId=f16789934520, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71f65411944, createdName=ms4000000798581120, createdTime=Sun Nov 15 18:01:08 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
    2020-11-17 jichang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1698166, encodeId=09651698166c1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 31 10:14:52 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826648, encodeId=b55218266489d, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jun 29 17:14:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423592, encodeId=02d21423592cf, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454873, encodeId=ff1e14548e331, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899345, encodeId=f16789934520, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71f65411944, createdName=ms4000000798581120, createdTime=Sun Nov 15 18:01:08 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
    2020-11-17 xiaoyeshuang
  5. [GetPortalCommentsPageByObjectIdResponse(id=1698166, encodeId=09651698166c1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 31 10:14:52 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826648, encodeId=b55218266489d, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jun 29 17:14:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423592, encodeId=02d21423592cf, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454873, encodeId=ff1e14548e331, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Tue Nov 17 06:14:52 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899345, encodeId=f16789934520, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71f65411944, createdName=ms4000000798581120, createdTime=Sun Nov 15 18:01:08 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
    2020-11-15 ms4000000798581120

    学习

    0

相关资讯

2016专家共识——成人短期外周静脉导管相关性感染的预防,诊断和治疗发布

使用血管内导管是二、三级医院常规操作规程,短期应用外周静脉导管已经被发现与院内菌血症相关,本文主要由西班牙心血管感染学会相关专家组制订,主要内容涉及静脉导管置入的适应症,导管维护和注册,导管相关感染的诊断和治疗等。全文获取:下载地址:指南下载 (需要扣积分2分, 梅斯医学APP免积分下载)

Lancet Infect Dis:“De-implementation ”策略用于降低不适当的外周静脉和尿导管使用率

"减少不恰当使用"降低了ICU外周静脉导管不当使用率,也一定程度上降低了导尿管不当使用率。这一策略的广泛使用有望减少与卫生保健有关的感染

Lancet haemat:检测外周静脉导管性静脉炎所存在的问题。

现有多种检测外周静脉导管(PVC)性静脉炎的仪器,但在临床实践中其适应症未达成一致。这种一致性的缺乏导致不能鉴定和比较医院内以及医院间由PVCs引起的静脉炎的比例,而在以往的研究中,该比例在2%-62%。